Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Treu Jesse I
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   55,258    

Indirect Shares

   2,983,502      
Direct Value   $37,649    

Indirect Value

   $10,776,798      
Total Shares   3,038,760      
Total Value   $10,814,447      


Northstar Neuroscience Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $80 Veracyte, Inc. $37,569 Northstar Neuroscience Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $80 Veracyte, Inc. $37,569
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX Director 2010-06-09 0 2009-12-18 0    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR Director 2007-05-18 17,231 2007-05-18 14,690    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 21,289 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 15,096 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA Director, 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT Director 2019-03-04 1,642 2019-03-04 1,641    Premium*  
            Tandem Diabetes Care Inc TNDM Director, 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Aldeyra Therapeutics, Inc. ALDX Director 2019-03-26 0 2019-03-26 8,763    Premium*  
* Premium Members only  

Records found :    157         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2012-05-31 4 A $0.00 $0 I/I 93,434 93,434 0 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 A $0.00 $0 I/I 2,244,125 16,529 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 A $0.00 $0 I/I 66,462 159,896 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 D $0.00 $0 I/I (1,000,000) 5,772,968 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 A $0.00 $0 I/I 1,816,474 30,462 0 -
TBRA Tobira Therapeutics Inc Director   –       •       •   2013-08-27 4 A $0.00 $0 I/I 1,800,109 14,920 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2013-09-30 4 A $0.00 $0 I/I 1,133,333 19,006 0 -
VCYT Veracyte, Inc. Director   –       •       •   2013-11-04 4 A $0.00 $0 I/I 3,086,024 22,730 0 -
TNDM Tandem Diabetes Care Inc Director   –       •       •   2013-11-19 4 A $0.00 $0 I/I 3,243,448 54,390 0 -
DRNA Dicerna Pharmaceuticals I... 10% Owner   –       –       •   2014-02-04 4 A $0.00 $0 I/I 1,765,711 13,004 0 -
AKAO Achaogen Inc 10% Owner   –       –       •   2014-03-17 4 A $0.00 $0 I/I 2,020,939 33,890 0 -
VCYT Veracyte, Inc. Director   –       •      –    2017-05-16 4 D $0.00 $0 I/I (25,245) 0 0 -
VCYT Veracyte, Inc. Director   –       •      –    2017-05-16 4 A $0.00 $0 I/I 1,641 1,641 0 -
VCYT Veracyte, Inc. Director   –       •      –    2017-05-16 4 A $0.00 $0 D/D 1,642 1,642 0 -
VCYT Veracyte, Inc. Director   –       •      –    2017-05-16 4 S $8.08 $17,986 I/I (2,226) 20,504 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2009-01-28 4 S $0.93 $34,131 I/I (36,700) 72,738 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2009-12-14 4 S $1.15 $40,250 I/I (35,000) 9,435 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2007-06-05 4 S $14.07 $49,245 I/I (3,500) 11,582 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 S $8.04 $55,589 I/I (6,914) 40,790 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2009-01-29 4 S $0.91 $57,330 I/I (63,000) 71,302 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2007-05-17 4 S $14.50 $62,307 I/I (4,297) 15,082 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2009-12-10 4 S $1.15 $66,125 I/I (57,500) 14,131 0 -
NUVA Nuvasive Inc 10% Owner   –       –       •   2004-05-18 4 D $11.00 $83,633 I/I (7,603) 1,744,013 -
NUVA Nuvasive Inc 10% Owner   –       –       •   2004-05-18 4 OE $0.63 $83,636 I/I 133,818 1,751,616 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •       •   2006-09-18 4 S $13.03 $84,161 I/I (6,459) 25,838 0 -
  157  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us